Vince & Associates will conduct an inpatient clinical trial on the psychological effects of an active ingredient in marijuana — cannabidiol — in support of a federal collaboration seeking to better understand the abuse potential of the substance.
Altasciences is pleased to share that they are in the final stages of completing the world’s first safety and tolerability study on a cannabis extract being developed as a new chemical entity for approval by the FDA and Health Canada as a drug.
Altasciences’ Chris Perkin Honored as One of 100 Most Inspiring Leaders in the Life Sciences Industry
Altasciences Clinical Research, one of the largest early phase Clinical Research Organizations (CROs) in North America, is pleased to announce that Chris Perkin, Chief Executive Officer, has been named one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine for a third consecutive year — an honor bestowed on individuals recognized for the positive impact they have had on the industry through their leadership, influence and positive actions.
Altasciences Clinical Research proudly announces that its companies, Algorithme Pharma and Vince & Associates Clinical Research, have each been awarded multiple 2017 CRO Leadership Awards.
OVERLAND PARK, KS (January 11, 2017) – Vince & Associates Clinical Research, an Altasciences company, announced today the opening of a controlled ventilation indoor vaping room at their clinical research unit in Overland Park, Kansas.